Skip to main content

Table 1 Clinical anti-viral treatment features of H7N9 patients in Guangdong province, China

From: Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment

Patient

Time (days) after onset of symptoms when anti-viral drugs were administered

Anti-viral drug used

Clinical outcome

1

22

Oseltamivir

Survival

2

8

3

8

4

7

Oseltamivir, China-made Peramivir

Survival

5

13

Oseltamivir, Zanamivir, China-made Peramivir

Death

6

9

Oseltamivir, Zanamivir

Survival

7

11

  1. *Some of these data were published by our research team, Zifeng Yang et al. [21]